Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation

Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation and bone destruction. Microbial infection is considered to be the most important inducement of RA. The pregnancy planning of women in childbearing age is seriously affected by the disease activity of RA. Gut mi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yao Yao, Xiaoyu Cai, Weidong Fei, Fujia Ren, Fengmei Wang, Xiaofei Luan, Fengying Chen, Caihong Zheng
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://doaj.org/article/ef77c2bf848f4e7295cf62fe26d853d4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ef77c2bf848f4e7295cf62fe26d853d4
record_format dspace
spelling oai:doaj.org-article:ef77c2bf848f4e7295cf62fe26d853d42021-11-05T16:50:59ZRegulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation1663-981210.3389/fphar.2020.594042https://doaj.org/article/ef77c2bf848f4e7295cf62fe26d853d42020-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2020.594042/fullhttps://doaj.org/toc/1663-9812Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation and bone destruction. Microbial infection is considered to be the most important inducement of RA. The pregnancy planning of women in childbearing age is seriously affected by the disease activity of RA. Gut microbiome, related to immunity and inflammatory response of the host. At present, emerging evidence suggested there are significant differences in the diversity and abundance of gut microbiome during pregnancy and lactation, which may be associated with the fluctuation of RA disease activity. Based on these research foundations, we pioneer the idea of regulating gut microbiome for the treatment of RA during pregnancy and lactation. In this review, we mainly introduce the potential treatment strategies for controlling the disease activity of RA based on gut microbiome during pregnancy and lactation. Besides, we also briefly generalize the effects of conventional anti-rheumatic drugs on gut microbiome, the effects of metabolic changes during pregnancy on gut microbiome, alteration of gut microbiome during pregnancy and lactation, and the effects of anti-rheumatic drugs commonly used during pregnancy and lactation on gut microbiome. These will provide a clear knowledge framework for researchers in immune-related diseases during pregnancy. Regulating gut microbiome may be a potential and effective treatment to control the disease activity of RA during pregnancy and lactation.Yao YaoXiaoyu CaiWeidong FeiFujia RenFengmei WangXiaofei LuanFengying ChenCaihong ZhengFrontiers Media S.A.articlegut microbiomerheumatoid arthritispregnancylactationtreatmentTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 11 (2020)
institution DOAJ
collection DOAJ
language EN
topic gut microbiome
rheumatoid arthritis
pregnancy
lactation
treatment
Therapeutics. Pharmacology
RM1-950
spellingShingle gut microbiome
rheumatoid arthritis
pregnancy
lactation
treatment
Therapeutics. Pharmacology
RM1-950
Yao Yao
Xiaoyu Cai
Weidong Fei
Fujia Ren
Fengmei Wang
Xiaofei Luan
Fengying Chen
Caihong Zheng
Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation
description Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation and bone destruction. Microbial infection is considered to be the most important inducement of RA. The pregnancy planning of women in childbearing age is seriously affected by the disease activity of RA. Gut microbiome, related to immunity and inflammatory response of the host. At present, emerging evidence suggested there are significant differences in the diversity and abundance of gut microbiome during pregnancy and lactation, which may be associated with the fluctuation of RA disease activity. Based on these research foundations, we pioneer the idea of regulating gut microbiome for the treatment of RA during pregnancy and lactation. In this review, we mainly introduce the potential treatment strategies for controlling the disease activity of RA based on gut microbiome during pregnancy and lactation. Besides, we also briefly generalize the effects of conventional anti-rheumatic drugs on gut microbiome, the effects of metabolic changes during pregnancy on gut microbiome, alteration of gut microbiome during pregnancy and lactation, and the effects of anti-rheumatic drugs commonly used during pregnancy and lactation on gut microbiome. These will provide a clear knowledge framework for researchers in immune-related diseases during pregnancy. Regulating gut microbiome may be a potential and effective treatment to control the disease activity of RA during pregnancy and lactation.
format article
author Yao Yao
Xiaoyu Cai
Weidong Fei
Fujia Ren
Fengmei Wang
Xiaofei Luan
Fengying Chen
Caihong Zheng
author_facet Yao Yao
Xiaoyu Cai
Weidong Fei
Fujia Ren
Fengmei Wang
Xiaofei Luan
Fengying Chen
Caihong Zheng
author_sort Yao Yao
title Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation
title_short Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation
title_full Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation
title_fullStr Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation
title_full_unstemmed Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation
title_sort regulating gut microbiome: therapeutic strategy for rheumatoid arthritis during pregnancy and lactation
publisher Frontiers Media S.A.
publishDate 2020
url https://doaj.org/article/ef77c2bf848f4e7295cf62fe26d853d4
work_keys_str_mv AT yaoyao regulatinggutmicrobiometherapeuticstrategyforrheumatoidarthritisduringpregnancyandlactation
AT xiaoyucai regulatinggutmicrobiometherapeuticstrategyforrheumatoidarthritisduringpregnancyandlactation
AT weidongfei regulatinggutmicrobiometherapeuticstrategyforrheumatoidarthritisduringpregnancyandlactation
AT fujiaren regulatinggutmicrobiometherapeuticstrategyforrheumatoidarthritisduringpregnancyandlactation
AT fengmeiwang regulatinggutmicrobiometherapeuticstrategyforrheumatoidarthritisduringpregnancyandlactation
AT xiaofeiluan regulatinggutmicrobiometherapeuticstrategyforrheumatoidarthritisduringpregnancyandlactation
AT fengyingchen regulatinggutmicrobiometherapeuticstrategyforrheumatoidarthritisduringpregnancyandlactation
AT caihongzheng regulatinggutmicrobiometherapeuticstrategyforrheumatoidarthritisduringpregnancyandlactation
_version_ 1718444138826825728